Century Therapeutics (IPSC) Assets Average (2021 - 2026)
Century Therapeutics (IPSC) posted quarterly Assets Average of $275.1 million for Q1 2026, down 17.73% year-over-year from $334.4 million in Q1 2025, and up 17.47% quarter-over-quarter from $234.2 million in Q4 2025.
Century Therapeutics (IPSC) Assets Average (2021 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Assets Average for 6 consecutive years, with $275.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 17.73% year-over-year to $275.1 million; the TTM figure through Mar 2026 stood at $275.1 million (down 17.73% YoY), while the FY2025 annual figure was $288.5 million, down 19.19% from the prior year.
- Assets Average advanced to $275.1 million in Q1 2026 per IPSC's latest filing, from $234.2 million in the prior quarter.
- Across five years, Assets Average topped out at $541.4 million in Q2 2022 and bottomed at $234.2 million in Q4 2025.
- Historically, Assets Average has averaged $392.4 million across 5 years, with a median of $382.5 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average advanced 10.05% — and 2025, when it slumped 36.86%.
- Century Therapeutics' Assets Average stood at $499.1 million in 2022, then fell by 24.05% to $379.1 million in 2023, then dropped by 2.16% to $370.9 million in 2024, then plunged by 36.86% to $234.2 million in 2025, then advanced by 17.47% to $275.1 million in 2026.
- Business Quant data shows IPSC's Assets Average at $275.1 million in Q1 2026, $234.2 million in Q4 2025, and $264.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 306.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 306.78 Mn |
| Mar 31, 2026 | 275.13 Mn |
| Dec 31, 2025 | 234.21 Mn |
| Sep 30, 2025 | 264.70 Mn |
| Jun 30, 2025 | 300.15 Mn |
| Mar 31, 2025 | 334.41 Mn |
| Dec 31, 2024 | 370.92 Mn |
| Sep 30, 2024 | 402.53 Mn |
| Jun 30, 2024 | 382.48 Mn |
| Mar 31, 2024 | 354.60 Mn |
| Dec 31, 2023 | 379.12 Mn |
| Sep 30, 2023 | 407.36 Mn |
| Jun 30, 2023 | 436.69 Mn |
| Mar 31, 2023 | 471.39 Mn |
| Dec 31, 2022 | 499.15 Mn |
| Sep 30, 2022 | 522.17 Mn |
| Jun 30, 2022 | 541.45 Mn |
| Mar 31, 2022 | 493.84 Mn |
| Dec 31, 2021 | 453.55 Mn |
| Sep 30, 2021 | 482.68 Mn |